Carcinoembryonic Antigen (CEA) Market 2018 SWOT Analysis by Major Eminent Players: Abbott Diagnostics, Quest Diagnostics and Roche Holding AG

A research study titled, “Carcinoembryonic Antigen (CEA) Market by Application - Global Industry Analysis and Forecast to 2022” published by Crystal Market Research, states that the Carcinoembryonic Antigen (CEA) Market Is Projected To Be Around $2.51 Billion By 2025.

Carcinoembryonic Antigen (CEA) Market Industry Trend Analysis
The Carcinoembryonic Antigen (CEA) Market was worth USD 1.36 billion in the year of 2012 and is expected to reach approximately USD 2.51 billion by 2022, while registering itself at a compound annual growth rate (CAGR) of 5.64% during the forecast period. The Global carcinoembryonic antigen market is anticipated to encounter significant development over the estimate time on account of factors like increasing predominance of cancer and the advancement of novel biomarkers. Evaluations distributed by the World Health Organization, recommend that in 2012, the overall cancer occurrences were almost 14.1 Million, which included 7.4 million male and 6.7 million female patients. The world Age-Standardized (AS) rate reflects that there are about 205 new cases of cancer for each 100,000 men globally, and 165 for each 100,000 women.

Access sample copy of this report @ https://www.crystalmarketresearch.com/report-sample/HC10279

Carcinoembryonic Antigen (CEA) Market Regional Analysis
Leading regional segments in of carcinoembryonic antigen market are Latin America, Europe, MEA, Asia Pacific and North America. The global market was dominated by North America on the basis of revenue in 2014 with a share of 46.3 percent due to high occurrence rates of cancer, existence of advanced healthcare framework and increasing awareness in patients. The existence of undiscovered opportunities, continuously enhancing healthcare framework, monetary improvement, and growing awareness in patients are a few elements representing this fast development. Moreover, yearly rates of colorectal cancer all around are more than 1 million and this rate is additionally anticipated to increase. The death rate recorded was around 490,000 of every 1990 and 715,000 out of 2010. Asia Pacific holds the most elevated rate of mortality, joined by North America. As indicated by the information distributed by the American Cancer Society in 2013, it has been assessed that the death rate of all types of cancers has kept on declining which began in mid-1990s. Asia Pacific has had a major influence on the market on the basis of cancer occurrence rates that affect a vast population at a rate that is changeable in 2012.

Carcinoembryonic Antigen (CEA) Market Competitive Insights
Major players in the market are Abbott Diagnostics, Quest Diagnostics and Roche Holding AG. Industry competition levels for this market are relied upon to stay at a respectably high level amid the estimate time frame. The market is united in nature and is therefore, set apart by a broad existence of acquisitions and mergers. These efforts are relied upon to raise the level of competition among key players. Makers confront thorough cost based rivalry and are likewise under steady pressure to present new and technologically propelled items.

Carcinoembryonic Antigen (CEA) Market By Application
• CEA Based Pancreatic Cancer
• CEA Based Ovarian Cancer
• CEA Based Thyroid Cancer
• CEA Based Colorectal Cancer
• CEA Based Breast Cancer
• Others

Browse Full Report With TOC @ https://www.crystalmarketresearch.com/report/carcinoembryonic-antigen-cea-market

Key findings of the Carcinoembryonic Antigen Market
• Colorectal cancer was one of the biggest profit producing application section of the carcinoembryonic antigen market and in 2014. Expanding pervasiveness of colorectal disease and use of carcinoembryonic antigen tests at different stages is one of the basic variables representing its substantial share. For example, in 2012, new instances of colorectal cancer were assessed to be more than 93,000 and passing because of colorectal cancer is required to be more than 49,700 in the United States alone.

• Carcinoembryonic antigen based breast cancer determination is distinguished as the most lucrative application fragment of the market. The market is driven by components, for example, developing number of female populace over 50 years, developing interest for cosmetic surgeries and Hormone Replacement Therapy (HRT). Besides, developing levels of awareness in patients and the existence of supportive government activities are relied upon to enhance treatment rates over the estimate time frame.

• In 2014 North America was the biggest regional market attributable to the existence of high frequency rates, good repayment structure, and high customer awareness levels combined with generally higher human services consumption levels.

• Asia Pacific is foreseen to witness significant development over the figure time frame. The existence of undiscovered opportunities, continuously enhancing human services systems, monetary advancement, and enhancing awareness levels of patient are a few elements representing this fast development.

To avail discount, please click on the link @ https://www.crystalmarketresearch.com/check-discount/HC10279

About Crystal Market Research:
Crystal Market Research is a U.S. based market research and business intelligence company. Crystal offers one stop solution for market research, business intelligence, and consulting services to help clients make more informed decisions. It provides both syndicated as well as customized research studies for its customers spread across the globe. The company offers market intelligence reports across a broad range of industries including healthcare, chemicals & materials, technology, automotive, and energy.

Contact:
Crystal Market Research
Judy
304 South Jones Blvd, Suite 1896,
Las Vegas NV 89107,
United States
Toll Free: +1-888-213-4282
Email: sales@crystalmarketresearch.com

This release was published on openPR.